SOUTH AFRICA

Home / Products / Pigs / Farrowsure® Gold B

Farrowsure® Gold B

Reg no. G3890 (Act 36/1947)

Primary vaccination

Farrowsure® Gold B is an inactivated vaccine that aids in the prevention of reproductive failure in sows caused by Erysipelas rhusiopathiae, Leptospira bratislava, L.canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. Pomona.

Expand All
  • Active Ingredients:
    • Inactivated porcine parvovirus, Erysipelas rhusiopathiae, Leptospira bratislava, L.
      canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae       and L. pomona vaccine
  • Indications:
    • For the vaccination of healthy breeding pigs as an aid in preventing reproductive failure caused by porcine parvovirus, erysipelas caused by Erysipelas rhusiopathiae, and Leptospirosis caused by Leptospira bratislava, L. canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona..
  • Directions For Use:
    • Vaccination of healthy breeding pigs is recommended. Shake well. Aseptically inject 2 ml intramuscularly.
    • Primary vaccination: Healthy pigs should receive 2 doses 3 to 5 weeks apart with the second dose administered 2 to 4 weeks prior to breeding. Healthy gilts, however, should receive their second dose as near as possible to 14 days prior to breeding.
    • Revaccination: Revaccination with a single dose is recommended prior to subsequent breeding. Boars should be revaccinated semi-annually.
  • Warnings:
    • Do not vaccinate within 21 days before slaughter
    • Vaccinate healthy pigs only
    • Keep out of reach of children, uninformed persons and animals
    • As with most vaccines, anaphylaxis may occur after use. Initial antidote of adrenaline is recommended and should be followed with the appropriate supportive therapy.
    • Transient local swelling at injection site may occur following vaccination.
    • This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished, or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
    • Good animal husbandry and herd health management practices should be employed.
    • Accidental self-injection could lead to severe transient local allergic reaction. Consult a physician and inform them the vaccine contains a mineral oil.
    • Although this vaccine has been extensively tested under a variety of conditions, failure thereof may ensue as a result of a wide variety of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
  • Contra-indications:
    Storage:
    • Store in the dark between 2°C and 7°C. Do not freeze. Prolonged exposure to higher temperatures and/or direct sunlight my adversely affect potency.

DISCLAIMER: ALTHOUGH GREAT CARE HAS BEEN TAKEN IN THE COMPILATION OF THIS DOCUMENT, READERS ARE REQUESTED TO REFER TO THE PACKAGE INSERT FOR COMPLETE DETAILS BEFORE USING THE SPECIFIC PRODUCT.

Ordering Products
Fax no. for Orders:
+27 21 427 6442
 
Email address for Orders:
ZoetisOrders@zoetis.com
 
Physical Address:
Zoetis South Africa (Pty) Ltd.
Co. Reg. No.: 2012/001825/07
6th Floor, North Wing, 90 Rivonia Road, Sandton, 2196.
 
Tel:
+27 11 245 3300 or 0860 ZOETIS (0860 963847)

Terms of sale

Postal Address

Zoetis South Africa (Pty) Ltd
PostNet Suite 53
Private Bag 9976
Sandton
2146